TAT-Beclin1 in vivo injection improves cardiac function in various heart disorders, including pressure overload, diabetic cardiomyopathy, and cardiac dysfunction by sepsis [9,10,111]. The gene discussed is BECN1; the disease is diabetic cardiomyopathy.